Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NKTX stock hub

Nkarta, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NKTXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
227.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
NKTX
In the news

Latest news · NKTX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.6P50 18.3P75 33.7
Trailing P/En/a
P25 15P50 23.3P75 38.5
ROE-28.9
P25 -106.6P50 -46.9P75 -3.1
ROIC-16.5
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NKTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001787400
Company name
Nkarta, Inc.
Country
United States
Country code
US
Cusip
65487U108
Employees
108
Employees Change
-49%
Employees Change Percent
-31.21
Enterprise value
$27.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2020-07-10
Isin
US65487U1088
Last refreshed
2026-05-10
Market cap
$227.4M
Market cap category
Micro-Cap
Price
$3.19
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
NKTX
Website
https://www.nkartatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-45.77%
FCF yield
-39.53%
P/B ratio
0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-104.1M
Net Income Growth Years
2%
Profit Per Employee
$-963,741
ROA
-15.99
Roa5y
-18.06
ROCE
-30.33
ROE
-28.9
Roe5y
-32.77
ROIC
-16.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
70.65%
Cagr3y
-11.68%
Cagr5y
-35.08%
EPS Growth Years
6
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$404.2M
Cash
$276.3M
Current Assets
$282.5M
Current Liabilities
$22.3M
Debt
$76.4M
Debt Equity
$0.24
Equity
$312.3M
Liabilities
$91.9M
Long Term Assets
$121.7M
Long Term Liabilities
$69.6M
Net Cash
$199.9M
Net Cash By Market Cap
$87.88
Net Cash Growth
6.83%
Net Debt Equity
$-0.64
Tangible Book Value
$312.3M
Tangible Book Value Per Share
$4.39
WACC
6.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
12.69
Net Working Capital
$-9.1M
Quick ratio
12.41
Working Capital
$260.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-9.03%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
70.59%
200-day SMA
2.2
3Y total return
-31.1%
50-day SMA
2.57
50-day SMA vs 200-day SMA
50over200
5Y total return
-88.47%
All Time High
79.16
All Time High Change
-95.97%
All Time High Date
2020-12-24
All Time Low
1.28
All Time Low Change
149.22%
All Time Low Date
2023-10-02
ATR
0.23
Beta
0.89
Beta1y
2
Beta2y
1.44
Ch YTD
72.43
High
3.26
High52
3.65
High52 Date
2026-04-21
High52ch
-12.6%
Low
3.1
Low52
1.63
Low52 Date
2025-07-01
Low52ch
95.71%
Ma50ch
24.27%
Premarket Change Percent
-1.59
Premarket Price
$3.1
Premarket Volume
715
Price vs 200-day SMA
44.74%
RSI
61.46
RSI Monthly
47.47
RSI Weekly
62.06
Sharpe ratio
1.05x
Sortino ratio
1.83
Total Return
-9.03%
Tr YTD
72.43
Tr1m
41.78%
Tr1w
8.87%
Tr3m
57.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
4
Analyst Count Top
2
Analyst Price Target Top
$11
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.37
Operating Income
$-115.8M
Price target
$11.33
Price Target Change
$255
Price Target Change Top
$245

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
56,625,103%
Float Percent
79.43%
Shares Insiders
0.41%
Shares Institutions
67.07%
Shares Out
71,290,925
Shares Qo Q
0.03%
Shares Yo Y
9.03%
Short Float
9.55%
Short Ratio
9.49
Short Shares
7.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
$-98.5M
Average Volume
1,151,237.5x
Bv Per Share
4.39
CAPEX
$-1.2M
Ch1m
41.78
Ch1w
8.87
Ch1y
70.59
Ch3m
57.92
Ch3y
-31.1
Ch5y
-88.47
Ch6m
62.76
Change
1.27%
Change From Open
1.92
Close
3.15
Days Gap
-0.63
Depreciation Amortization
9,193,000
Dollar Volume
2,173,975.4
Earnings Date
2026-05-11
Earnings Time
amc
EBIT
$-115.8M
EBITDA
$-106.6M
EPS
$-1.41
F Score
1
FCF
$-89.9M
FCF EV Yield
-326.23x
FCF Per Share
$-1.26
Financing CF
141,000
Fiscal Year End
December
Founded
2,015
Investing CF
100,319,000
Ipr
-82.28
Iprfo
-94.17
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-25
Ma150
2.23
Ma150ch
42.92%
Ma20
2.94
Ma20ch
8.47%
Net CF
11,761,000
Next Earnings Date
2026-05-22
Open
3.13
Optionable
Yes
Position In Range
56.25
Post Close
3.19
Postmarket Change Percent
1.88
Postmarket Price
$3.25
Ppne
101,150,000
Pre Close
3.15
Price Date
2026-05-08
Ptbv Ratio
0.73
Relative Volume
0.59x
Share Based Comp
8,559,000
Tr6m
62.76%
Us State
California
Volume
681,497
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NKTX pay a dividend?

Capital-return profile for this ticker.

Performance

NKTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+70.6%
S&P 500 1Y: n/a
3Y total return
-31.1%
S&P 500 3Y: n/a
5Y total return
-88.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NKTX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+67.1%
Float: +79.4% of shares outstanding
Insider ownership
+0.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+9.5%
9.5 days to cover
Y/Y dilution
+9.0%
Negative means the company is buying back shares.
Technical

NKTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.5
Neutral momentum band
Price vs 200-day MA
+44.7%
50/200-day relationship not available
Beta (5Y)
0.89
Moves roughly with the market
Sharpe ratio
1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NKTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NKTX stock rating?

Nkarta, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NKTX analysis?

The full report lives at /stocks/NKTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NKTX?

The latest report frames NKTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NKTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.